ADVFN
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,231.16
      0.02%
      US Tech 100
      22,104.80
      0.11%
      Dow Jones
      44,315.47
      -0.20%
      Brent Oil
      69.58
      0.45%
      Bitcoin
      108,524.00
      0.19%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Armata Pharmaceuticals Inc (ARMP)

      7. Armata Pharmaceuticals Inc (ARMP) News

      ARMP

      Armata Pharmaceuticals (ARMP)

      Armata Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:ARMP
      DateTimeSourceHeadlineSymbolCompany
      12:30PMiHub NewswireFeaturedFifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment
      06/13/20254:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      05/14/20254:23PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
      05/14/20254:13PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      05/01/20257:07AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      04/28/20255:04PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:ARMPArmata Pharmaceuticals Inc
      04/28/20255:01PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
      04/25/20254:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      04/25/20254:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      04/25/20254:05PMEdgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
      04/02/20254:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      03/12/20255:49PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
      03/12/20255:14PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      02/07/20254:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
      12/19/20247:38AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      12/04/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      11/15/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      11/14/20244:17PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
      11/13/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
      11/13/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      11/12/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
      10/03/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
       Showing the most relevant articles for your search:AMEX:ARMP